Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
Case Report
 
Esophageal vasculitis in granulomatosis with polyangiitis
Keywords :
Suceena Alexander1, Ebby George Simon2, Deepak Burad3, Santosh Varughese1, VinoI George David1, Shibu Jacob1, Golla Sudhakar1, Veerasamy Tamilarasi1, Chakko Korula Jacob1, Charles D Pusey4,
Department of Nephrology1, Gastroenterology2,

General Pathology3,
Christian Medical College,
Vellore, India and
Department of Medicine4,
Imperial College, London


Corresponding Author
: Dr. Suceena Alexander
Email: suceena@gmail.com


DOI: http://dx.doi.org/10.7869/tg.270

48uep6bbphidvals|730
48uep6bbph|2000F98CTab_Articles|Fulltext
Granulomatosis with polyangiitis (GPA; formerly Wegener’s granulomatosis) affects the gastrointestinal tract infrequently as compared to other small or medium vessel vasculitis. Case reports of lower gastrointestinal (GI) involvement in GPA are numerous but esophageal vasculitis due to GPA is extremely rare. Only six cases of esophageal involvement in GPA have been reported in the literature thus far. We present the diagnostic and treatment challenges in a case of esophageal ulceration due to GPA and review the relevant literature.

Case report

A 56-year old Asian woman was referred to the Nephrology outpatient services for evaluation of renal impairment. She gave history of dysphagia for the preceding one year, which was slowly progressive and more for solids than liquids. There was associated regurgitation of gastric contents, post-prandial fullness and reflux symptoms. She also reported recurrent, itchy, painless purpuric lesions over the lower limbs for the past 2 months, along with ulcers over both ankles and blisters over the hands and feet. She gave a history of recurrent painless oral ulcers, loss of weight of 7 kg over the past 3 months, loss of appetite and arthralgia mainly involving the large joints. She experienced an episode of severe upper abdominal pain a month before presentation, associated with 10 to 12 episodes of increased bowel movements with altered blood, which was managed conservatively. She had occasional diffuse, poorly localized abdominal pain, with no particular relation to food.

She did not have any symptoms associated with the genitourinary system. Her baseline serum creatinine a month before presentation was 0.9 mg/dL. She was treated elsewhere for bilateral episcleritis 8 months previously with topical and oral steroids. She had since been intermittently on oral steroids.

She did not give history of any addiction.

On examination, she looked unwell, blood pressure was 120/80 mm Hg, pulse was 84 per minute and temperature was 36.90 C. She had palpable purpura over the trunk and extremities. Necrotic ulcers 4 cm x 4 cm were present over both lateral malleoli and a smaller 2 cm x 2 cm ulcer over the lateral aspect of the left leg. Examination of the oral cavity revealed three lingual ulcers ranging from 1 to 2 cm with raised edges and necrotic centers. Blood investigations showed a white blood cell count of 12.9 x 103 cells per cumm, hemoglobin of 9.6 g/dL, platelet count of 4.62 x 105 cells per cumm, ESR 40 mm at one hour, serum creatinine 2.1 mg/dL, estimated glomerular filtration rate (eGFR) of 25.8 ml/min/1.73m2, normal liver function tests, negative serology for anti-nuclear antibody (ANA), topoisomerase 1 (Scl 70), anti-ribonucleo protein (anti-RNP), anti-centromere antibodies (CENP), anti- Jo 1, absence of serum cryoglobulins, normal C3, C4 complements, rheumatoid factor titre of 141 IU/Ml, negative hepatitis B surface antigen and hepatitis C antibody levels. Anti-neutrophilic cytoplasmic antibody was positive for cytoplasmic ANCA (c-ANCA) at 300 U. Urine analysis showed dipstick protein of 1+, 20-25 urine RBCs per high power field and 4-6 urine WBCs per high power field. 24-hour urine protein was 448 mg. Barium swallow revealed persistent luminal narrowing with mucosal irregularity of the distal third of the esophagus and significant gastroesophageal reflux. Upper GI endoscopy revealed diffuse circumferential lower esophageal ulceration, with significant luminal narrowing preventing further intubation (Figure 1).



Esophageal biopsy showed extensive ulceration, with no evidence of dysplasia or malignancy. A Ryle’s tube was placed over a guidewire under fluoroscopy. Biopsy of the tongue ulcer showed epithelial hyperplasia and ulceration, with no evidence of malignancy. Punch biopsy of the skin showed evidence of leucocytoclastic vasculitis. Renal biopsy was reported as pauci immune focal segmental proliferative and sclerosing glomerulonephritis.

The patient satisfied the American College of Rheumatology
criteria for GPA and fulfilled the definition of GPA in the Chapel Hill Consensus Conference. She received intravenous pulses of methylprednisolone for three consecutive days, but succumbed to sudden massive pulmonary hemorrhage a day after completing the pulse therapy. Autopsy was performed with consent of next of kin. Gross and microscopic examination confirmed the cause of death as massive pulmonary haemorrhage. The esophageal mucosa at the lower one third was granular and ulcerated (Figure 2), and showed transmural inflammation comprising of neutrophils, lymphocytes and histiocytes with fibrosis of lamina propria. There was evidence of leucocytoclastic vasculitis with fibrinoid necrosis of the vessel walls (Figure 3). There were two incidentally detected perforations 1.5 cm and 1.0 cm in diameter about 150 cm from the ileocaecal valve. The small intestinal wall near the perforation also had necrotic debris, acute fibrinous exudates and transmural infiltrates of neutrophils and monocytes. Histology of the kidney was consistent with the renal biopsy findings.



The differentials for these ulcerative lesions in the esophagus also include infective causes like Candida and Cytomegalovirus (CMV). On endoscopy, there were no curdy white precipitates suggestive of candida. The gross specimen of the esophagus on autopsy did not show any features of Candida (Figure 2). There was no evidence of Candida or CMV inclusions on histopathology.



Discussion

The first two cases of GPA on record were those of Klinger (1931) and Rossle (1933), but it was Friedrich Wegener (1936, 1939) who first described the disease in detail, and hence the name “Wegener’s granulomatosis” (WG). Recently it has been renamed as “granulomatosis with polyangiitis (GPA)”.[1] The pathological features of GPA were defined by Godman and Churg (1954), with a diagnostic triad of necrotizing granulomas of upper and lower respiratory tract, panvasculitis and focal glomerulonephritis, but these were largely based on autopsy studies.[2] Limited forms of GPA, with no renal involvement, and increased patient survival, were first described by Carrington and Liebow in 1966. Fauci et al, in their series of 85 patients with GPA proposed that the diagnosis requires clinical involvement in two of three sites (upper airways, lungs and kidney) along with histological confirmation in preferably two sites, though one site may suffice.

Gastrointestinal vasculitis does not generally occur in isolation, and is associated more frequently with polyarteritis nodosa, Churg-Strauss or microscopic polyangitis rather than GPA,[3] and is reported in about 5-11% of cases. The symptoms are mostly loss of appetite, pain, diarrhea or hematochezia.

Esophageal involvement has been described only in six previous case reports of GPA,[4,5] with one being an asymptomatic esophageal arteritis found during autopsy study.

Upper GI endoscopy is helpful in defining the extent of involvement. Out of the seven case reports (including ours), six had endoscopic evaluation. Esophageal ulcerations were discrete and punched out in four of these reports. Diffuse circumferential esophageal ulcerations were present in the other two case reports (including ours), and could represent an advanced disease state as these patients died of disease complications despite immunosuppression.[4] Endoscopic biopsies were nonspecific and not diagnostic in four out of the six cases (including ours). It has been suggested that endoscopic biopsies are superficial and may not be diagnostic.[3]

Interestingly, in four of these reports (including ours), dysphagia was the prominent symptom. Esophageal involvement can also be the presenting symptom of GPA as seen in our case.

Physicians need to be aware of GPA as a cause of esophageal ulcers, to prevent delay in diagnosis and treatment. In the present case, the decision to administer high dose steroids had to be weighed against the risk of precipitating GI hemorrhage. Management of such cases is essentially high dose immunosuppression, as generally used in the induction phase of vasculitis. Esophageal strictures may require serial dilatation.[5] This report highlights esophageal involvement as a rare presentation of GPA.

References
  1. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, et al. Granulomatosis with Polyangiitis (Wegener’s): An alternative name for Wegener’s Granulomatosis. Arthritis Rheum. 2011;63:863–4.
  2. Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954;58:533–53.
  3. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. Q J Med. 1983;52:141–9. Figure 1: USG showing duplication cyst (Typical gut signature)
  4. Fallows GA, Hamilton SF, Taylor DS, Reddy SB. Esophageal involvement in Wegener’s granulomatosis: a case report and review of the literature. Can J Gastroenterol. 2000;14:449–51.
  5. Reddy RS, Biyyani S, Pauskar P, Fahmy NM, King JF. Extensive gastrointestinal tract and thyroid involvement with Wegeners granulomatosis. Indian J Gastroenterol. 2007;26:290–1.